PBYI Insider Trading Activity - Puma Biotechnology, Inc.
Robert Gadimian Charged with Insider Trading
Puma Biotech (NYSE: PBYI) Stock Skyrockets 300% on Breast Cancer Breakthrough
Former Puma Biotechnology exec is accused of making $1.2 million from insider trading - Los Angeles Times
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Stock (NASDAQ:PBYI), Quotes and News Summary - Benzinga
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
PUMA BIOTECHNOLOGY, INC.
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotechnology to Move Stock Exchange Listing to Nasdaq | Business Wire
Puma Biotechnology: Waiting For Commercial Numbers To Catch Up To Clinical Data (NASDAQ:PBYI) | Seeking Alpha
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology Executives Under Investigation for Breast Cancer Drug — Schubert Jonckheer & Kolbe
Puma Biotechnology wins extension for U.S. patent related to breast cancer therapy | Seeking Alpha
What Happened To Puma Biotechnology?
Puma Biotechnology (NASDAQ:PBYI) Stock Price News
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotechnology Inc Share Price USD0.0001
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Puma shares nearly triple on drug news, but options smell 'fishy'
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace
The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
